Systemic IL-6 and Severe Asthma.
作者信息
Lipworth Brian, Chan Rory, Kuo Chris
机构信息
University of Dundee, Scotland, United Kingdom.
出版信息
Am J Respir Crit Care Med. 2020 Nov 1;202(9):1324-1325. doi: 10.1164/rccm.202006-2354LE.
Abstract
摘要
相似文献
1
Systemic IL-6 and Severe Asthma.全身性白细胞介素-6与重度哮喘
Am J Respir Crit Care Med. 2020 Nov 1;202(9):1324-1325. doi: 10.1164/rccm.202006-2354LE.
2
Emerging interleukin receptor antagonists for the treatment of asthma.用于治疗哮喘的新型白细胞介素受体拮抗剂
Expert Opin Emerg Drugs. 2017 Sep;22(3):275-283. doi: 10.1080/14728214.2017.1369954. Epub 2017 Aug 23.
3
Severe Eosinophilic Allergic Asthma Responsive to Mepolizumab After Failure of 2 Consecutive Biologics.在连续两种生物制剂治疗失败后对美泊利珠单抗有反应的重度嗜酸性粒细胞性过敏性哮喘
J Investig Allergol Clin Immunol. 2019 Feb;29(1):79-81. doi: 10.18176/jiaci.0340.
4
Reslizumab in the treatment of severe eosinophilic asthma: an update.瑞利珠单抗治疗重度嗜酸性粒细胞性哮喘：最新进展
Immunotherapy. 2018 Jun;10(8):695-698. doi: 10.2217/imt-2017-0176. Epub 2018 Mar 20.
5
A Critical Evaluation of Anti-IL-13 and Anti-IL-4 Strategies in Severe Asthma.重度哮喘中抗白细胞介素-13和抗白细胞介素-4策略的批判性评估
Int Arch Allergy Immunol. 2016;170(2):122-31. doi: 10.1159/000447692. Epub 2016 Aug 3.
6
Targeting the interleukin-4 and interleukin-13 pathways in severe asthma: current knowledge and future needs.靶向严重哮喘中的白细胞介素-4 和白细胞介素-13 通路：现有知识和未来需求。
Curr Opin Pulm Med. 2018 Jan;24(1):50-55. doi: 10.1097/MCP.0000000000000436.
7
IL-5 in asthma.白细胞介素-5与哮喘
Thorax. 2002 Aug;57(8):751. doi: 10.1136/thorax.57.8.751.
8
The tralokinumab story: Nothing is ever simple.曲罗芦单抗的故事：世事无绝对简单之事。
J Allergy Clin Immunol. 2019 Apr;143(4):1336-1338. doi: 10.1016/j.jaci.2018.12.1005. Epub 2019 Jan 16.
9
Recent developments in the use of biologics targeting IL-5, IL-4, or IL-13 in severe refractory asthma.在严重难治性哮喘中针对 IL-5、IL-4 或 IL-13 使用生物制剂的最新进展。
Expert Rev Respir Med. 2018 Nov;12(11):957-963. doi: 10.1080/17476348.2018.1520095. Epub 2018 Sep 17.
10
Treatment Challenges in Severe Eosinophilic Asthma: Differential Response to Anti-IL-5 and Anti-IL-5R Therapy.重度嗜酸性粒细胞性哮喘的治疗挑战：抗白细胞介素-5 和抗白细胞介素-5 受体治疗的差异反应。
Int J Mol Sci. 2021 Apr 12;22(8):3969. doi: 10.3390/ijms22083969.
引用本文的文献
1
TNFSF11/TNFRSF11A Axis Amplifies HDM-Induced Airway Remodeling by Strengthening TGFβ1/STAT3 Action.TNFSF11/TNFRSF11A轴通过增强TGFβ1/STAT3作用放大了屋尘螨诱导的气道重塑。
Allergy Asthma Immunol Res. 2024 Jul;16(4):399-421. doi: 10.4168/aair.2024.16.4.399.
2
Transformed Root Extract Reduces Pro-Inflammatory Cytokines and Promotes Tissue Repair In Vitro.转化根提取物可减少炎症细胞因子并促进体外组织修复。
Int J Environ Res Public Health. 2023 Mar 7;20(6):4706. doi: 10.3390/ijerph20064706.
3
Screening of Q-markers for the wine-steamed Schisandra chinensis decoction pieces in improving allergic asthma.筛选酒蒸五味子饮片改善过敏性哮喘的Q-标志物
Chin Med. 2023 Jan 30;18(1):10. doi: 10.1186/s13020-023-00712-0.
4
Beneficial effects of infrared light-emitting diode in corticosteroid-resistant asthma.红外发光二极管对皮质激素抵抗性哮喘的有益作用。
Lasers Med Sci. 2022 Apr;37(3):1963-1971. doi: 10.1007/s10103-021-03457-0. Epub 2021 Nov 6.
5
Cytokine antibody array-based analysis of IL-37 treatment effects in asthma.基于细胞因子抗体阵列的哮喘中 IL-37 治疗效果分析。
Aging (Albany NY). 2021 Sep 13;13(17):21729-21742. doi: 10.18632/aging.203515.
6
Interleukin-6 promotes ferroptosis in bronchial epithelial cells by inducing reactive oxygen species-dependent lipid peroxidation and disrupting iron homeostasis.白细胞介素-6 通过诱导活性氧依赖的脂质过氧化和破坏铁平衡促进支气管上皮细胞发生铁死亡。
Bioengineered. 2021 Dec;12(1):5279-5288. doi: 10.1080/21655979.2021.1964158.
7
Role of IL-6 in Severe Inflammation.白细胞介素-6在严重炎症中的作用。
Am J Respir Crit Care Med. 2021 Jan 1;203(1):140-141. doi: 10.1164/rccm.202007-3001LE.
本文引用的文献
1
Evidence for Exacerbation-Prone Asthma and Predictive Biomarkers of Exacerbation Frequency.哮喘加重倾向的证据和加重频率的预测生物标志物。
Am J Respir Crit Care Med. 2020 Oct 1;202(7):973-982. doi: 10.1164/rccm.201909-1813OC.
2
Extrafine triple therapy in patients with asthma and persistent airflow limitation.哮喘合并持续性气流受限患者的超精细三联疗法
Eur Respir J. 2020 Sep 24;56(3). doi: 10.1183/13993003.00476-2020. Print 2020 Sep.
3
Inhibitory effects of glycopyrronium, formoterol, and budesonide on coronavirus HCoV-229E replication and cytokine production by primary cultures of human nasal and tracheal epithelial cells.格隆溴铵、福莫特罗和布地奈德对人鼻和气管上皮细胞原代培养物中冠状病毒HCoV-229E复制及细胞因子产生的抑制作用。
Respir Investig. 2020 May;58(3):155-168. doi: 10.1016/j.resinv.2019.12.005. Epub 2020 Feb 21.
4
Acute lung injury induces cardiovascular dysfunction: effects of IL-6 and budesonide/formoterol.急性肺损伤导致心血管功能障碍：白细胞介素 6 和布地奈德/福莫特罗的影响。
Am J Respir Cell Mol Biol. 2011 Sep;45(3):510-6. doi: 10.1165/rcmb.2010-0169OC. Epub 2010 Dec 17.
5
Elevation of IL-6 in the allergic asthmatic airway is independent of inflammation but associates with loss of central airway function.过敏性哮喘气道中白细胞介素 6 的升高与炎症无关，但与中央气道功能丧失有关。
Respir Res. 2010 Mar 8;11(1):28. doi: 10.1186/1465-9921-11-28.
6
Lower airway disease in asthmatics with and without rhinitis.有鼻炎和无鼻炎的哮喘患者的下气道疾病
Lung. 2008 Nov-Dec;186(6):361-8. doi: 10.1007/s00408-008-9119-1. Epub 2008 Oct 9.
Zotero 插件